JavaScript is off. Please enable to view full site.

Guinea trial shows 'historic' success for Ebola vaccine

Friday, December 23, 2016, 08:31 GMT+7

A vaccine developed by Merck is the first shown to be highly effective in preventing human infection with Ebola, according to final results from a clinical trial.

Among 5,837 people who received the rVSV-EBOV vaccine in the trial in Guinea in 2015, no Ebola cases were recorded 10 days or more after vaccination, signaling 100 percent protection.

More than 11,300 people died in West Africa's 2013-2016 epidemic of the virus, which causes hemorrhagic fever.

"When the next Ebola outbreak hits, we will not be defenceless," said Marie-Paule Kieny, a World Health Organization (WHO) assistant director-general and one of the lead researchers in the trial.

Merck's rVSV-EBOV has already been used in Sierra Leone to contain a flare-up there.

The Guinea trial took place in the coastal region of Basse-Guinée, which was still seeing new Ebola cases when the trial started in 2015.

It used a "ring vaccination" approach, in which, when a new Ebola case was diagnosed, researchers traced all people who might have been in recent contact and logged them as clusters, or "rings", made up of an average of 80 people.

At first, the clusters were assigned to receive the vaccine either immediately or after a three-week delay. After interim results showed 100 percent protection in those vaccinated immediately, the trial design was switched to allow all clusters to be given the shot straight away.

The WHO said that if Ebola outbreaks occurred before the vaccine was given full regulatory approval, it could be made available though a compassionate use procedure after informed consent.

John Edmunds, a professor of infectious disease modeling at the London School of Hygiene & Tropical Medicine, whose team helped design the trial, hailed its success as "historic".

"When Ebola strikes again we will be in a much better position to offer help to affected communities, as well as protect the brave volunteers who help control this terrible disease," he said in an emailed statement.

GAVI, the global vaccine alliance, provided $5 million earlier this year to buy 300,000 doses of rVSV-EBOV as a stockpile for use during future Ebola outbreaks.



Read more




Experience summer sand-boarding in Mui Ne

Sand-boarding, a popular activity amongst local children in the coastal tourism town of Mui Ne in south-central Vietnam, is attracting hundreds of tourists to the Red Sand Dunes

Young maple trees given better protection as Hanoi enters rainy season

The trees are currently growing well, with green leaves and healthy branches.

Hunting skinks for food in southern Vietnam

Skink meat is known to be soft, tasty, and highly nutritious.

Vietnamese-made app allows people to grow real veggies via smartphone

Nguyen Thi Duyen, a young engineer in Hanoi, developed the app and its related services to help busy people create their own veggie gardens.

Chinese tourists hit by Vietnamese over dine and dash

Four Chinese were reportedly injured, with one having a broken arm.

Latest news